+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Hepatorenal Syndrome (HRS) Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Condition Type (Type 1 Hepatorenal Syndrome , Type 2 Hepatorenal Syndrome ), By Therapeutic Modality (Pharmacotherapy , Surgical & Interventional Therapies , Renal Replacement Therapy ), By Route of Administration (Intravenous, Oral), By End-User (Hospitals & Intensive Care Units , Specialized Hepatology & Nephrology Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Hepatorenal Syndrome (HRS) Treatment Market size is forecast to increase from $5.78 Billion in 2026 to $10.01 Billion in 2034 at a CAGR of 7.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007597
Pages: 228 Pages

Hepatocellular Carcinoma (HCC) Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Targeted Therapies , Immunotherapy , Chemotherapy, Combination Therapies), By Treatment Modality (First-line Treatment, Second-line Treatment, Adjuvant Therapy), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-User (Hospitals, Specialty Oncology Clinics, Ambulatory Surgical Centers (ASCs)) Companies, and Country Forecast, 2021 to 2034

Global Hepatocellular Carcinoma (HCC) Drugs Market size is forecast to increase from $11.68 Billion in 2026 to $32.39 Billion in 2034 at a CAGR of 13.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007596
Pages: 224 Pages

Hepatitis Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A, D, and E), By Drug Class (Nucleoside, NS5A, Protease Inhibitors, Multi-class Combinations, Interferons, Monoclonal Antibodies), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis Therapeutics Market size is forecast to increase from $18.64 Billion in 2026 to $25.91 Billion in 2034 at a CAGR of 4.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007595
Pages: 216 Pages

Hepatitis Testing Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A, D, and E), By Technology (Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS) Panels), By Product Type (Reagents & Kits, Instruments & Analyzers, Software & Services), By End-User (Hospital & Clinical Laboratories, Blood Banks, Point-of-Care & Physician Offices, Home Testing & Self-Collection) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis Testing Market size is forecast to increase from $3.46 Billion in 2026 to $5.07 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007594
Pages: 224 Pages

Hepatitis E Diagnostic Tests Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (ELISA Kits , PCR, Rapid Lateral-Flow Tests, Confirmatory Tests ), By Sample Type (Serum, Stool, Viral RNA Detection Samples), By End User (Hospitals & Clinics, Diagnostic Reference Laboratories, Blood Banks & Transfusion Centers, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis E Diagnostic Tests Market size is forecast to increase from $70.74 Million in 2026 to $106.12 Million in 2034 at a CAGR of 5.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007593
Pages: 220 Pages

Hepatitis Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Nucleotide Polymerase, Hepatitis C Protease, Interferon Alphas, Nucleoside Analogue Antivirals, NS5A Inhibitors, Thrombopoiesis Stimulating Agents), By Disease Type (Hepatitis B, Hepatitis C), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis Drugs Market size is forecast to increase from $18.48 Billion in 2026 to $25.1 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007592
Pages: 224 Pages

Hepatitis Diagnostic Test Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents & Kits, Instruments & Analyzers, Software & Services), By Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis ), By Technology (Serology Tests, Rapid Diagnostic Tests, Molecular Tests, Next-Generation Sequencing Panels), By Sample Type (Blood, Saliva, Urine), By Test Setting (Hospital Laboratories, Reference Laboratories, Blood Banks, Point-of-Care, Home Testing & Self-Collection) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis Diagnostic Test Market size is forecast to increase from $4.6 Billion in 2026 to $7.96 Billion in 2034 at a CAGR of 7.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007591
Pages: 217 Pages

Hepatitis C Market Size, Share and Growth Outlook, 2026: Analysis By Market Component (Treatment Market, Diagnostics Market), By Target Age Group (Adults , Older Adults , Pediatric Population ), By Service Provider & Channel (Hospitals & Specialized Liver Clinics, Commercial Diagnostic Laboratories, Community Pharmacies & Retail Health Centers) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis C Market size is forecast to increase from $177.92 Billion in 2026 to $234.29 Billion in 2034 at a CAGR of 3.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007590
Pages: 221 Pages

Hepatitis C Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Fixed-Dose Combination Drugs, NS5A Inhibitors, NS3, NS5B Polymerase Inhibitors, Interferon & Ribavirin Antivirals), By Product (Combination Therapy, Monotherapy), By Disease Type Focus (Chronic Hepatitis C, Acute Hepatitis C), By Route of Administration (Oral Administration, Intravenous Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis C Drugs Market size is forecast to increase from $15.43 Billion in 2026 to $20.48 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007589
Pages: 213 Pages

Hepatitis B Vaccines Market Size, Share and Growth Outlook, 2026: Analysis By Vaccine Type (Mono , Combination Vaccines), By Technology (Recombinant DNA Vaccines, Plasma-Derived Vaccines), By Target Patient Group (Pediatric , Adult Population), By Distribution Channel (Hospitals & Specialized Vaccination Centers, Government Suppliers & Public Health Agencies, Retail Pharmacies & Private Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis B Vaccines Market size is forecast to increase from $3.2 Billion in 2026 to $4.12 Billion in 2034 at a CAGR of 3.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007588
Pages: 228 Pages